Clinical Trial: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980428) titled 'A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels' on May 19.

Brief Summary: The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ascending doses of AZD4954 in healthy participants with or without elevated Lipoprotein(a) (Lp[a]) levels.

Study Start Date: May 26

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: AZD4954

AZD4954 will be administered orally.

DRUG: Placebo

Placebo will be ...